| 000 | 01783 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514222212.0 | ||
| 264 | 0 | _c20051006 | |
| 008 | 200510s 0 0 eng d | ||
| 022 | _a0003-4967 | ||
| 024 | 7 |
_a10.1136/ard.2004.032441 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRudwaleit, M | |
| 245 | 0 | 0 |
_aMagnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept. _h[electronic resource] |
| 260 |
_bAnnals of the rheumatic diseases _cSep 2005 |
||
| 300 |
_a1305-10 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 | _aContrast Media |
| 650 | 0 | 4 | _aEtanercept |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aGadolinium DTPA |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xtherapeutic use |
| 650 | 0 | 4 |
_aMagnetic Resonance Imaging _xmethods |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xtherapeutic use |
| 650 | 0 | 4 |
_aSacroiliac Joint _xpathology |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aSpine _xpathology |
| 650 | 0 | 4 |
_aSpondylarthritis _xdrug therapy |
| 650 | 0 | 4 |
_aSpondylitis, Ankylosing _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aBaraliakos, X | |
| 700 | 1 | _aListing, J | |
| 700 | 1 | _aBrandt, J | |
| 700 | 1 | _aSieper, J | |
| 700 | 1 | _aBraun, J | |
| 773 | 0 |
_tAnnals of the rheumatic diseases _gvol. 64 _gno. 9 _gp. 1305-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/ard.2004.032441 _zAvailable from publisher's website |
| 999 |
_c15450222 _d15450222 |
||